MetLife, Inc. (NYSE:MET) saw a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 12,434,952 shares, a decrease of 21.6% from the October 31st total of 15,854,719 shares. Based on an average daily volume of 4,307,232 shares, the short-interest ratio is presently 2.9 days. Currently, 1.4% of the company’s shares are sold short.

A number of brokerages have recently commented on MET. Goldman Sachs Group began coverage on MetLife in a research note on Wednesday, October 18th. They issued a “conviction-buy” rating and a $61.00 price target for the company. Langen Mcalenn reaffirmed a “buy” rating on shares of MetLife in a research note on Wednesday, August 16th. B. Riley reaffirmed a “neutral” rating on shares of MetLife in a research note on Monday, November 6th. Wells Fargo & Company reaffirmed a “buy” rating on shares of MetLife in a research note on Monday, August 7th. Finally, BidaskClub raised MetLife from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $58.40.

Shares of MetLife (NYSE MET) opened at $52.65 on Wednesday. MetLife has a 52 week low of $44.26 and a 52 week high of $55.91. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a market capitalization of $54,540.66, a P/E ratio of 9.97, a P/E/G ratio of 1.30 and a beta of 1.51.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.19. MetLife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The business had revenue of $16.10 billion during the quarter, compared to analysts’ expectations of $15.47 billion. During the same period in the prior year, the business earned $1.28 EPS. MetLife’s revenue for the quarter was up 1.7% compared to the same quarter last year. analysts anticipate that MetLife will post 4.43 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 13th. Investors of record on Monday, November 6th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, November 3rd. This represents a $1.60 dividend on an annualized basis and a yield of 3.04%. MetLife’s payout ratio is -320.00%.

In other MetLife news, insider Christopher G. Townsend sold 55,712 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the transaction, the insider now directly owns 25,181 shares in the company, valued at approximately $1,367,076.49. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Christopher G. Townsend sold 82,731 shares of the company’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the transaction, the insider now owns 49,660 shares in the company, valued at $2,711,436. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Steward Partners Investment Advisory LLC acquired a new position in MetLife during the 3rd quarter worth approximately $867,000. First Fiduciary Investment Counsel Inc. boosted its position in MetLife by 1.3% during the 3rd quarter. First Fiduciary Investment Counsel Inc. now owns 306,685 shares of the financial services provider’s stock worth $15,932,000 after acquiring an additional 3,975 shares during the last quarter. Salem Investment Counselors Inc. boosted its position in MetLife by 21.9% during the 3rd quarter. Salem Investment Counselors Inc. now owns 42,330 shares of the financial services provider’s stock worth $2,205,000 after acquiring an additional 7,596 shares during the last quarter. Gyroscope Capital Management Group LLC boosted its position in MetLife by 14.2% during the 3rd quarter. Gyroscope Capital Management Group LLC now owns 116,392 shares of the financial services provider’s stock worth $6,047,000 after acquiring an additional 14,457 shares during the last quarter. Finally, Moors & Cabot Inc. boosted its position in MetLife by 12.6% during the 3rd quarter. Moors & Cabot Inc. now owns 20,252 shares of the financial services provider’s stock worth $1,051,000 after acquiring an additional 2,264 shares during the last quarter. 76.37% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “MetLife, Inc. (MET) Short Interest Update” was posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/29/metlife-inc-met-short-interest-update.html.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.